[Human cytomegalovirus infection].
Tanaka-Taya
Keiko
K
Infectious Disease Surveillance Center, National Institute of Infectious Diseases.
D000998:Antiviral Agents / Q000627:therapeutic use; D003587:Cytomegalovirus; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D005914:Globins / Q000627:therapeutic use; D006801:Humans; D016219:Immunotherapy, Adoptive; D014765:Viral Vaccines
D000998:Antiviral Agents; D014765:Viral Vaccines; D017245:Foscarnet; D005914:Globins; D015774:Ganciclovir